nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCG2—Vismodegib—skin cancer	0.0793	0.101	CbGbCtD
Omeprazole—ABCC3—Fluorouracil—skin cancer	0.0685	0.0872	CbGbCtD
Omeprazole—ABCG2—Vemurafenib—skin cancer	0.0626	0.0798	CbGbCtD
Omeprazole—CYP1A2—Imiquimod—skin cancer	0.0471	0.06	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—skin cancer	0.0452	0.0576	CbGbCtD
Omeprazole—CYP1A1—Dacarbazine—skin cancer	0.0443	0.0564	CbGbCtD
Omeprazole—CYP2C8—Vismodegib—skin cancer	0.0422	0.0538	CbGbCtD
Omeprazole—ABCG2—Dactinomycin—skin cancer	0.0416	0.053	CbGbCtD
Omeprazole—CYP2C19—Vismodegib—skin cancer	0.0354	0.0451	CbGbCtD
Omeprazole—CYP2C9—Vismodegib—skin cancer	0.0294	0.0375	CbGbCtD
Omeprazole—ABCB1—Vismodegib—skin cancer	0.0286	0.0364	CbGbCtD
Omeprazole—ABCG2—Fluorouracil—skin cancer	0.0281	0.0358	CbGbCtD
Omeprazole—CYP1A2—Vemurafenib—skin cancer	0.0258	0.0329	CbGbCtD
Omeprazole—CYP3A4—Imiquimod—skin cancer	0.0247	0.0315	CbGbCtD
Omeprazole—CYP3A4—Temozolomide—skin cancer	0.0247	0.0315	CbGbCtD
Omeprazole—ABCG2—Docetaxel—skin cancer	0.0215	0.0274	CbGbCtD
Omeprazole—CYP2D6—Vemurafenib—skin cancer	0.0213	0.0271	CbGbCtD
Omeprazole—CYP1A2—Dacarbazine—skin cancer	0.0198	0.0252	CbGbCtD
Omeprazole—CYP3A4—Vismodegib—skin cancer	0.0171	0.0218	CbGbCtD
Omeprazole—ABCB1—Dactinomycin—skin cancer	0.015	0.0191	CbGbCtD
Omeprazole—CYP2C8—Fluorouracil—skin cancer	0.015	0.0191	CbGbCtD
Omeprazole—CYP3A4—Vemurafenib—skin cancer	0.0135	0.0172	CbGbCtD
Omeprazole—CYP1A2—Fluorouracil—skin cancer	0.0116	0.0148	CbGbCtD
Omeprazole—CYP2C9—Fluorouracil—skin cancer	0.0105	0.0133	CbGbCtD
Omeprazole—ABCB1—Docetaxel—skin cancer	0.00775	0.00987	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—skin cancer	0.00464	0.00591	CbGbCtD
Omeprazole—ATP4A—neck—skin cancer	0.00148	0.0903	CbGeAlD
Omeprazole—ATP4A—connective tissue—skin cancer	0.00106	0.0647	CbGeAlD
Omeprazole—ATP4A—epithelium—skin cancer	0.001	0.0614	CbGeAlD
Omeprazole—CYP1B1—hair follicle—skin cancer	0.000876	0.0536	CbGeAlD
Omeprazole—CYP1A1—skin epidermis—skin cancer	0.000868	0.0531	CbGeAlD
Omeprazole—ATP4A—female reproductive system—skin cancer	0.000746	0.0456	CbGeAlD
Omeprazole—CYP2C18—mammalian vulva—skin cancer	0.000716	0.0438	CbGeAlD
Omeprazole—CYP11A1—connective tissue—skin cancer	0.000694	0.0424	CbGeAlD
Omeprazole—ATP4A—head—skin cancer	0.000624	0.0381	CbGeAlD
Omeprazole—CYP11A1—female reproductive system—skin cancer	0.000489	0.0299	CbGeAlD
Omeprazole—CYP1A2—nipple—skin cancer	0.000426	0.026	CbGeAlD
Omeprazole—CYP1B1—connective tissue—skin cancer	0.000421	0.0258	CbGeAlD
Omeprazole—CYP1A1—nipple—skin cancer	0.00042	0.0257	CbGeAlD
Omeprazole—CYP11A1—head—skin cancer	0.000409	0.025	CbGeAlD
Omeprazole—CYP1B1—skin of body—skin cancer	0.00038	0.0233	CbGeAlD
Omeprazole—ABCC3—female reproductive system—skin cancer	0.00038	0.0232	CbGeAlD
Omeprazole—ABCC3—head—skin cancer	0.000317	0.0194	CbGeAlD
Omeprazole—CYP1B1—lymphoid tissue—skin cancer	0.000308	0.0188	CbGeAlD
Omeprazole—ABCB1—blood vessel—skin cancer	0.000302	0.0185	CbGeAlD
Omeprazole—CYP1B1—female reproductive system—skin cancer	0.000297	0.0182	CbGeAlD
Omeprazole—CYP11A1—lymph node—skin cancer	0.000286	0.0175	CbGeAlD
Omeprazole—CYP1A1—epithelium—skin cancer	0.000283	0.0173	CbGeAlD
Omeprazole—CYP1A1—skin of body—skin cancer	0.000269	0.0164	CbGeAlD
Omeprazole—ABCG2—mammalian vulva—skin cancer	0.000258	0.0158	CbGeAlD
Omeprazole—CYP1B1—head—skin cancer	0.000248	0.0152	CbGeAlD
Omeprazole—CYP1A1—mammalian vulva—skin cancer	0.000245	0.015	CbGeAlD
Omeprazole—CYP2C8—female reproductive system—skin cancer	0.000228	0.0139	CbGeAlD
Omeprazole—ABCC3—lymph node—skin cancer	0.000222	0.0136	CbGeAlD
Omeprazole—Rhinitis—Fluorouracil—skin cancer	0.000214	0.00108	CcSEcCtD
Omeprazole—Dizziness—Vemurafenib—skin cancer	0.000213	0.00107	CcSEcCtD
Omeprazole—Hypoaesthesia—Fluorouracil—skin cancer	0.000212	0.00107	CcSEcCtD
Omeprazole—Pharyngitis—Fluorouracil—skin cancer	0.000212	0.00107	CcSEcCtD
Omeprazole—CYP1A1—female reproductive system—skin cancer	0.00021	0.0128	CbGeAlD
Omeprazole—Immune system disorder—Temozolomide—skin cancer	0.000209	0.00106	CcSEcCtD
Omeprazole—Mediastinal disorder—Temozolomide—skin cancer	0.000209	0.00105	CcSEcCtD
Omeprazole—Cough—Bleomycin—skin cancer	0.000209	0.00105	CcSEcCtD
Omeprazole—Chills—Temozolomide—skin cancer	0.000208	0.00105	CcSEcCtD
Omeprazole—Ill-defined disorder—Dactinomycin—skin cancer	0.000207	0.00104	CcSEcCtD
Omeprazole—Anaemia—Dactinomycin—skin cancer	0.000206	0.00104	CcSEcCtD
Omeprazole—Vomiting—Vemurafenib—skin cancer	0.000205	0.00103	CcSEcCtD
Omeprazole—Alopecia—Temozolomide—skin cancer	0.000205	0.00103	CcSEcCtD
Omeprazole—Dry skin—Docetaxel—skin cancer	0.000204	0.00103	CcSEcCtD
Omeprazole—Chest pain—Bleomycin—skin cancer	0.000204	0.00103	CcSEcCtD
Omeprazole—Myalgia—Bleomycin—skin cancer	0.000204	0.00103	CcSEcCtD
Omeprazole—Abdominal pain upper—Docetaxel—skin cancer	0.000203	0.00103	CcSEcCtD
Omeprazole—Rash—Vemurafenib—skin cancer	0.000203	0.00102	CcSEcCtD
Omeprazole—Mental disorder—Temozolomide—skin cancer	0.000203	0.00102	CcSEcCtD
Omeprazole—Dermatitis—Vemurafenib—skin cancer	0.000203	0.00102	CcSEcCtD
Omeprazole—Hypersensitivity—Imiquimod—skin cancer	0.000202	0.00102	CcSEcCtD
Omeprazole—CYP2C9—female reproductive system—skin cancer	0.000202	0.0124	CbGeAlD
Omeprazole—Headache—Vemurafenib—skin cancer	0.000202	0.00102	CcSEcCtD
Omeprazole—Malnutrition—Temozolomide—skin cancer	0.000202	0.00102	CcSEcCtD
Omeprazole—Breast disorder—Docetaxel—skin cancer	0.000201	0.00102	CcSEcCtD
Omeprazole—Discomfort—Bleomycin—skin cancer	0.000201	0.00101	CcSEcCtD
Omeprazole—Malaise—Dactinomycin—skin cancer	0.000201	0.00101	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000201	0.00101	CcSEcCtD
Omeprazole—Cramp muscle—Docetaxel—skin cancer	0.000201	0.00101	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000201	0.00101	CcSEcCtD
Omeprazole—Leukopenia—Dactinomycin—skin cancer	0.0002	0.00101	CcSEcCtD
Omeprazole—Dysgeusia—Temozolomide—skin cancer	0.000198	0.000997	CcSEcCtD
Omeprazole—Asthenia—Imiquimod—skin cancer	0.000197	0.000994	CcSEcCtD
Omeprazole—Confusional state—Bleomycin—skin cancer	0.000197	0.000993	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000196	0.000991	CcSEcCtD
Omeprazole—Anaphylactic shock—Bleomycin—skin cancer	0.000195	0.000985	CcSEcCtD
Omeprazole—Back pain—Temozolomide—skin cancer	0.000195	0.000984	CcSEcCtD
Omeprazole—Pruritus—Imiquimod—skin cancer	0.000194	0.000981	CcSEcCtD
Omeprazole—Infection—Bleomycin—skin cancer	0.000194	0.000978	CcSEcCtD
Omeprazole—Dysphagia—Docetaxel—skin cancer	0.000193	0.000971	CcSEcCtD
Omeprazole—Nausea—Vemurafenib—skin cancer	0.000191	0.000965	CcSEcCtD
Omeprazole—Thrombocytopenia—Bleomycin—skin cancer	0.000191	0.000964	CcSEcCtD
Omeprazole—Vision blurred—Temozolomide—skin cancer	0.00019	0.000959	CcSEcCtD
Omeprazole—Myalgia—Dactinomycin—skin cancer	0.00019	0.000958	CcSEcCtD
Omeprazole—Bronchospasm—Docetaxel—skin cancer	0.000189	0.000955	CcSEcCtD
Omeprazole—Tremor—Temozolomide—skin cancer	0.000189	0.000953	CcSEcCtD
Omeprazole—Alopecia—Fluorouracil—skin cancer	0.000189	0.000952	CcSEcCtD
Omeprazole—Diarrhoea—Imiquimod—skin cancer	0.000188	0.000948	CcSEcCtD
Omeprazole—Discomfort—Dactinomycin—skin cancer	0.000188	0.000946	CcSEcCtD
Omeprazole—Angina pectoris—Docetaxel—skin cancer	0.000188	0.000946	CcSEcCtD
Omeprazole—Ill-defined disorder—Temozolomide—skin cancer	0.000187	0.000944	CcSEcCtD
Omeprazole—Anaemia—Temozolomide—skin cancer	0.000186	0.000941	CcSEcCtD
Omeprazole—Anorexia—Bleomycin—skin cancer	0.000186	0.000939	CcSEcCtD
Omeprazole—Agitation—Temozolomide—skin cancer	0.000185	0.000935	CcSEcCtD
Omeprazole—Angioedema—Temozolomide—skin cancer	0.000184	0.00093	CcSEcCtD
Omeprazole—Pancytopenia—Docetaxel—skin cancer	0.000183	0.000922	CcSEcCtD
Omeprazole—Malaise—Temozolomide—skin cancer	0.000182	0.000918	CcSEcCtD
Omeprazole—Dizziness—Imiquimod—skin cancer	0.000182	0.000916	CcSEcCtD
Omeprazole—Vertigo—Temozolomide—skin cancer	0.000181	0.000914	CcSEcCtD
Omeprazole—Infection—Dactinomycin—skin cancer	0.000181	0.000912	CcSEcCtD
Omeprazole—Leukopenia—Temozolomide—skin cancer	0.000181	0.000911	CcSEcCtD
Omeprazole—Neutropenia—Docetaxel—skin cancer	0.00018	0.000908	CcSEcCtD
Omeprazole—Palpitations—Temozolomide—skin cancer	0.000178	0.000899	CcSEcCtD
Omeprazole—Thrombocytopenia—Dactinomycin—skin cancer	0.000178	0.000899	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000178	0.000897	CcSEcCtD
Omeprazole—Cough—Temozolomide—skin cancer	0.000176	0.000888	CcSEcCtD
Omeprazole—CYP1A1—head—skin cancer	0.000175	0.0107	CbGeAlD
Omeprazole—Paraesthesia—Bleomycin—skin cancer	0.000175	0.000884	CcSEcCtD
Omeprazole—Weight increased—Docetaxel—skin cancer	0.000175	0.000884	CcSEcCtD
Omeprazole—Vision blurred—Fluorouracil—skin cancer	0.000175	0.000884	CcSEcCtD
Omeprazole—Vomiting—Imiquimod—skin cancer	0.000175	0.000881	CcSEcCtD
Omeprazole—Weight decreased—Docetaxel—skin cancer	0.000174	0.000879	CcSEcCtD
Omeprazole—Hypertension—Temozolomide—skin cancer	0.000174	0.000879	CcSEcCtD
Omeprazole—Dyspnoea—Bleomycin—skin cancer	0.000174	0.000878	CcSEcCtD
Omeprazole—CYP1B1—lymph node—skin cancer	0.000174	0.0106	CbGeAlD
Omeprazole—Anorexia—Dactinomycin—skin cancer	0.000174	0.000875	CcSEcCtD
Omeprazole—Rash—Imiquimod—skin cancer	0.000173	0.000874	CcSEcCtD
Omeprazole—Dermatitis—Imiquimod—skin cancer	0.000173	0.000873	CcSEcCtD
Omeprazole—Headache—Imiquimod—skin cancer	0.000172	0.000868	CcSEcCtD
Omeprazole—Anaemia—Fluorouracil—skin cancer	0.000172	0.000867	CcSEcCtD
Omeprazole—Arthralgia—Temozolomide—skin cancer	0.000172	0.000866	CcSEcCtD
Omeprazole—Myalgia—Temozolomide—skin cancer	0.000172	0.000866	CcSEcCtD
Omeprazole—Infestation—Docetaxel—skin cancer	0.000172	0.000866	CcSEcCtD
Omeprazole—Infestation NOS—Docetaxel—skin cancer	0.000172	0.000866	CcSEcCtD
Omeprazole—Anxiety—Temozolomide—skin cancer	0.000171	0.000863	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000171	0.00086	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00017	0.000859	CcSEcCtD
Omeprazole—Discomfort—Temozolomide—skin cancer	0.00017	0.000856	CcSEcCtD
Omeprazole—Decreased appetite—Bleomycin—skin cancer	0.00017	0.000856	CcSEcCtD
Omeprazole—Renal failure—Docetaxel—skin cancer	0.000169	0.000851	CcSEcCtD
Omeprazole—Dry mouth—Temozolomide—skin cancer	0.000168	0.000847	CcSEcCtD
Omeprazole—Jaundice—Docetaxel—skin cancer	0.000167	0.000844	CcSEcCtD
Omeprazole—Stomatitis—Docetaxel—skin cancer	0.000167	0.000844	CcSEcCtD
Omeprazole—Pain—Bleomycin—skin cancer	0.000167	0.000842	CcSEcCtD
Omeprazole—Conjunctivitis—Docetaxel—skin cancer	0.000167	0.000842	CcSEcCtD
Omeprazole—Leukopenia—Fluorouracil—skin cancer	0.000166	0.000839	CcSEcCtD
Omeprazole—Confusional state—Temozolomide—skin cancer	0.000166	0.000837	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000166	0.000837	CcSEcCtD
Omeprazole—Anaphylactic shock—Temozolomide—skin cancer	0.000165	0.000831	CcSEcCtD
Omeprazole—Infection—Temozolomide—skin cancer	0.000164	0.000825	CcSEcCtD
Omeprazole—Nausea—Imiquimod—skin cancer	0.000163	0.000823	CcSEcCtD
Omeprazole—Hepatobiliary disease—Docetaxel—skin cancer	0.000162	0.000819	CcSEcCtD
Omeprazole—Epistaxis—Docetaxel—skin cancer	0.000162	0.000817	CcSEcCtD
Omeprazole—Nervous system disorder—Temozolomide—skin cancer	0.000161	0.000815	CcSEcCtD
Omeprazole—Thrombocytopenia—Temozolomide—skin cancer	0.000161	0.000813	CcSEcCtD
Omeprazole—Feeling abnormal—Bleomycin—skin cancer	0.000161	0.000811	CcSEcCtD
Omeprazole—Agranulocytosis—Docetaxel—skin cancer	0.00016	0.000808	CcSEcCtD
Omeprazole—Skin disorder—Temozolomide—skin cancer	0.00016	0.000807	CcSEcCtD
Omeprazole—Hyperhidrosis—Temozolomide—skin cancer	0.000159	0.000803	CcSEcCtD
Omeprazole—Chest pain—Fluorouracil—skin cancer	0.000158	0.000798	CcSEcCtD
Omeprazole—Myalgia—Fluorouracil—skin cancer	0.000158	0.000798	CcSEcCtD
Omeprazole—Decreased appetite—Dactinomycin—skin cancer	0.000158	0.000798	CcSEcCtD
Omeprazole—Fatigue—Dactinomycin—skin cancer	0.000157	0.000792	CcSEcCtD
Omeprazole—Anorexia—Temozolomide—skin cancer	0.000157	0.000792	CcSEcCtD
Omeprazole—Discomfort—Fluorouracil—skin cancer	0.000156	0.000789	CcSEcCtD
Omeprazole—Pain—Dactinomycin—skin cancer	0.000156	0.000785	CcSEcCtD
Omeprazole—Urticaria—Bleomycin—skin cancer	0.000155	0.000782	CcSEcCtD
Omeprazole—Rhinitis—Docetaxel—skin cancer	0.000155	0.000779	CcSEcCtD
Omeprazole—Body temperature increased—Bleomycin—skin cancer	0.000154	0.000778	CcSEcCtD
Omeprazole—Hepatitis—Docetaxel—skin cancer	0.000154	0.000777	CcSEcCtD
Omeprazole—CYP3A4—female reproductive system—skin cancer	0.000154	0.00943	CbGeAlD
Omeprazole—Hypoaesthesia—Docetaxel—skin cancer	0.000153	0.000774	CcSEcCtD
Omeprazole—Confusional state—Fluorouracil—skin cancer	0.000153	0.000772	CcSEcCtD
Omeprazole—Pharyngitis—Docetaxel—skin cancer	0.000153	0.000772	CcSEcCtD
Omeprazole—Urinary tract disorder—Docetaxel—skin cancer	0.000152	0.000768	CcSEcCtD
Omeprazole—Oedema peripheral—Docetaxel—skin cancer	0.000152	0.000766	CcSEcCtD
Omeprazole—Anaphylactic shock—Fluorouracil—skin cancer	0.000152	0.000765	CcSEcCtD
Omeprazole—CYP2D6—female reproductive system—skin cancer	0.000152	0.00928	CbGeAlD
Omeprazole—Connective tissue disorder—Docetaxel—skin cancer	0.000151	0.000764	CcSEcCtD
Omeprazole—Urethral disorder—Docetaxel—skin cancer	0.000151	0.000762	CcSEcCtD
Omeprazole—Infection—Fluorouracil—skin cancer	0.000151	0.00076	CcSEcCtD
Omeprazole—Feeling abnormal—Dactinomycin—skin cancer	0.00015	0.000757	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00015	0.000757	CcSEcCtD
Omeprazole—Insomnia—Temozolomide—skin cancer	0.000149	0.000751	CcSEcCtD
Omeprazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000149	0.000751	CcSEcCtD
Omeprazole—Nervous system disorder—Fluorouracil—skin cancer	0.000149	0.00075	CcSEcCtD
Omeprazole—Thrombocytopenia—Fluorouracil—skin cancer	0.000149	0.000749	CcSEcCtD
Omeprazole—Visual impairment—Docetaxel—skin cancer	0.000149	0.000749	CcSEcCtD
Omeprazole—Tachycardia—Fluorouracil—skin cancer	0.000148	0.000747	CcSEcCtD
Omeprazole—Paraesthesia—Temozolomide—skin cancer	0.000148	0.000746	CcSEcCtD
Omeprazole—ABCB1—epithelium—skin cancer	0.000147	0.00898	CbGeAlD
Omeprazole—Dyspnoea—Temozolomide—skin cancer	0.000147	0.00074	CcSEcCtD
Omeprazole—Somnolence—Temozolomide—skin cancer	0.000146	0.000738	CcSEcCtD
Omeprazole—Erythema multiforme—Docetaxel—skin cancer	0.000146	0.000735	CcSEcCtD
Omeprazole—Dyspepsia—Temozolomide—skin cancer	0.000145	0.000731	CcSEcCtD
Omeprazole—Anorexia—Fluorouracil—skin cancer	0.000145	0.000729	CcSEcCtD
Omeprazole—Eye disorder—Docetaxel—skin cancer	0.000144	0.000727	CcSEcCtD
Omeprazole—Abdominal pain—Dactinomycin—skin cancer	0.000144	0.000726	CcSEcCtD
Omeprazole—Body temperature increased—Dactinomycin—skin cancer	0.000144	0.000726	CcSEcCtD
Omeprazole—Hypersensitivity—Bleomycin—skin cancer	0.000144	0.000725	CcSEcCtD
Omeprazole—Decreased appetite—Temozolomide—skin cancer	0.000143	0.000722	CcSEcCtD
Omeprazole—Flushing—Docetaxel—skin cancer	0.000143	0.000722	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000142	0.000717	CcSEcCtD
Omeprazole—Fatigue—Temozolomide—skin cancer	0.000142	0.000716	CcSEcCtD
Omeprazole—Constipation—Temozolomide—skin cancer	0.000141	0.00071	CcSEcCtD
Omeprazole—Pain—Temozolomide—skin cancer	0.000141	0.00071	CcSEcCtD
Omeprazole—Asthenia—Bleomycin—skin cancer	0.00014	0.000706	CcSEcCtD
Omeprazole—Immune system disorder—Docetaxel—skin cancer	0.000139	0.000702	CcSEcCtD
Omeprazole—Mediastinal disorder—Docetaxel—skin cancer	0.000139	0.000701	CcSEcCtD
Omeprazole—Chills—Docetaxel—skin cancer	0.000138	0.000698	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000138	0.000697	CcSEcCtD
Omeprazole—Pruritus—Bleomycin—skin cancer	0.000138	0.000697	CcSEcCtD
Omeprazole—Insomnia—Fluorouracil—skin cancer	0.000137	0.000692	CcSEcCtD
Omeprazole—Paraesthesia—Fluorouracil—skin cancer	0.000136	0.000687	CcSEcCtD
Omeprazole—Alopecia—Docetaxel—skin cancer	0.000136	0.000687	CcSEcCtD
Omeprazole—Feeling abnormal—Temozolomide—skin cancer	0.000136	0.000684	CcSEcCtD
Omeprazole—Dyspnoea—Fluorouracil—skin cancer	0.000135	0.000682	CcSEcCtD
Omeprazole—Mental disorder—Docetaxel—skin cancer	0.000135	0.000681	CcSEcCtD
Omeprazole—Somnolence—Fluorouracil—skin cancer	0.000135	0.00068	CcSEcCtD
Omeprazole—Gastrointestinal pain—Temozolomide—skin cancer	0.000135	0.000679	CcSEcCtD
Omeprazole—Malnutrition—Docetaxel—skin cancer	0.000134	0.000677	CcSEcCtD
Omeprazole—Hypersensitivity—Dactinomycin—skin cancer	0.000134	0.000677	CcSEcCtD
Omeprazole—Dyspepsia—Fluorouracil—skin cancer	0.000134	0.000674	CcSEcCtD
Omeprazole—Decreased appetite—Fluorouracil—skin cancer	0.000132	0.000665	CcSEcCtD
Omeprazole—Dysgeusia—Docetaxel—skin cancer	0.000131	0.000663	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000131	0.000661	CcSEcCtD
Omeprazole—Urticaria—Temozolomide—skin cancer	0.000131	0.00066	CcSEcCtD
Omeprazole—Asthenia—Dactinomycin—skin cancer	0.000131	0.000659	CcSEcCtD
Omeprazole—Body temperature increased—Temozolomide—skin cancer	0.00013	0.000657	CcSEcCtD
Omeprazole—Abdominal pain—Temozolomide—skin cancer	0.00013	0.000657	CcSEcCtD
Omeprazole—Back pain—Docetaxel—skin cancer	0.00013	0.000655	CcSEcCtD
Omeprazole—Pain—Fluorouracil—skin cancer	0.00013	0.000654	CcSEcCtD
Omeprazole—ABCG2—lymph node—skin cancer	0.000129	0.00792	CbGeAlD
Omeprazole—Muscle spasms—Docetaxel—skin cancer	0.000129	0.000651	CcSEcCtD
Omeprazole—ABCB1—mammalian vulva—skin cancer	0.000127	0.00779	CbGeAlD
Omeprazole—CYP2D6—head—skin cancer	0.000127	0.00775	CbGeAlD
Omeprazole—Feeling abnormal—Fluorouracil—skin cancer	0.000125	0.000631	CcSEcCtD
Omeprazole—Diarrhoea—Dactinomycin—skin cancer	0.000125	0.000628	CcSEcCtD
Omeprazole—Vomiting—Bleomycin—skin cancer	0.000124	0.000626	CcSEcCtD
Omeprazole—Anaemia—Docetaxel—skin cancer	0.000124	0.000626	CcSEcCtD
Omeprazole—Rash—Bleomycin—skin cancer	0.000123	0.000621	CcSEcCtD
Omeprazole—Dermatitis—Bleomycin—skin cancer	0.000123	0.00062	CcSEcCtD
Omeprazole—CYP1A1—lymph node—skin cancer	0.000123	0.00751	CbGeAlD
Omeprazole—Hypersensitivity—Temozolomide—skin cancer	0.000121	0.000612	CcSEcCtD
Omeprazole—Urticaria—Fluorouracil—skin cancer	0.000121	0.000608	CcSEcCtD
Omeprazole—Leukopenia—Docetaxel—skin cancer	0.00012	0.000606	CcSEcCtD
Omeprazole—Body temperature increased—Fluorouracil—skin cancer	0.00012	0.000605	CcSEcCtD
Omeprazole—Palpitations—Docetaxel—skin cancer	0.000119	0.000598	CcSEcCtD
Omeprazole—Asthenia—Temozolomide—skin cancer	0.000118	0.000596	CcSEcCtD
Omeprazole—Cough—Docetaxel—skin cancer	0.000117	0.000591	CcSEcCtD
Omeprazole—Pruritus—Temozolomide—skin cancer	0.000116	0.000588	CcSEcCtD
Omeprazole—Nausea—Bleomycin—skin cancer	0.000116	0.000585	CcSEcCtD
Omeprazole—Hypertension—Docetaxel—skin cancer	0.000116	0.000584	CcSEcCtD
Omeprazole—Vomiting—Dactinomycin—skin cancer	0.000116	0.000584	CcSEcCtD
Omeprazole—Rash—Dactinomycin—skin cancer	0.000115	0.000579	CcSEcCtD
Omeprazole—Arthralgia—Docetaxel—skin cancer	0.000114	0.000576	CcSEcCtD
Omeprazole—Chest pain—Docetaxel—skin cancer	0.000114	0.000576	CcSEcCtD
Omeprazole—Myalgia—Docetaxel—skin cancer	0.000114	0.000576	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000113	0.000572	CcSEcCtD
Omeprazole—ABCB1—lymphoid tissue—skin cancer	0.000113	0.00692	CbGeAlD
Omeprazole—Diarrhoea—Temozolomide—skin cancer	0.000113	0.000568	CcSEcCtD
Omeprazole—Hypersensitivity—Fluorouracil—skin cancer	0.000112	0.000564	CcSEcCtD
Omeprazole—Dry mouth—Docetaxel—skin cancer	0.000112	0.000563	CcSEcCtD
Omeprazole—Confusional state—Docetaxel—skin cancer	0.00011	0.000557	CcSEcCtD
Omeprazole—Anaphylactic shock—Docetaxel—skin cancer	0.00011	0.000552	CcSEcCtD
Omeprazole—ABCB1—female reproductive system—skin cancer	0.000109	0.00667	CbGeAlD
Omeprazole—Dizziness—Temozolomide—skin cancer	0.000109	0.000549	CcSEcCtD
Omeprazole—Infection—Docetaxel—skin cancer	0.000109	0.000549	CcSEcCtD
Omeprazole—Nausea—Dactinomycin—skin cancer	0.000108	0.000545	CcSEcCtD
Omeprazole—Shock—Docetaxel—skin cancer	0.000108	0.000543	CcSEcCtD
Omeprazole—Nervous system disorder—Docetaxel—skin cancer	0.000107	0.000542	CcSEcCtD
Omeprazole—Pruritus—Fluorouracil—skin cancer	0.000107	0.000541	CcSEcCtD
Omeprazole—Thrombocytopenia—Docetaxel—skin cancer	0.000107	0.000541	CcSEcCtD
Omeprazole—Tachycardia—Docetaxel—skin cancer	0.000107	0.000539	CcSEcCtD
Omeprazole—Skin disorder—Docetaxel—skin cancer	0.000106	0.000536	CcSEcCtD
Omeprazole—Vomiting—Temozolomide—skin cancer	0.000105	0.000528	CcSEcCtD
Omeprazole—Anorexia—Docetaxel—skin cancer	0.000104	0.000526	CcSEcCtD
Omeprazole—Rash—Temozolomide—skin cancer	0.000104	0.000524	CcSEcCtD
Omeprazole—Diarrhoea—Fluorouracil—skin cancer	0.000104	0.000524	CcSEcCtD
Omeprazole—Dermatitis—Temozolomide—skin cancer	0.000104	0.000523	CcSEcCtD
Omeprazole—Headache—Temozolomide—skin cancer	0.000103	0.00052	CcSEcCtD
Omeprazole—Dizziness—Fluorouracil—skin cancer	0.0001	0.000506	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Docetaxel—skin cancer	9.98e-05	0.000503	CcSEcCtD
Omeprazole—Insomnia—Docetaxel—skin cancer	9.9e-05	0.0005	CcSEcCtD
Omeprazole—Paraesthesia—Docetaxel—skin cancer	9.83e-05	0.000496	CcSEcCtD
Omeprazole—Nausea—Temozolomide—skin cancer	9.78e-05	0.000493	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—skin cancer	9.76e-05	0.000492	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—skin cancer	9.73e-05	0.000491	CcSEcCtD
Omeprazole—Vomiting—Fluorouracil—skin cancer	9.65e-05	0.000487	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—skin cancer	9.64e-05	0.000486	CcSEcCtD
Omeprazole—Rash—Fluorouracil—skin cancer	9.57e-05	0.000483	CcSEcCtD
Omeprazole—Dermatitis—Fluorouracil—skin cancer	9.56e-05	0.000482	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—skin cancer	9.52e-05	0.00048	CcSEcCtD
Omeprazole—Headache—Fluorouracil—skin cancer	9.5e-05	0.000479	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—skin cancer	9.45e-05	0.000477	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—skin cancer	9.44e-05	0.000476	CcSEcCtD
Omeprazole—Pain—Docetaxel—skin cancer	9.36e-05	0.000472	CcSEcCtD
Omeprazole—Constipation—Docetaxel—skin cancer	9.36e-05	0.000472	CcSEcCtD
Omeprazole—ABCB1—head—skin cancer	9.11e-05	0.00557	CbGeAlD
Omeprazole—Feeling abnormal—Docetaxel—skin cancer	9.02e-05	0.000455	CcSEcCtD
Omeprazole—Nausea—Fluorouracil—skin cancer	9.01e-05	0.000455	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—skin cancer	8.95e-05	0.000452	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—skin cancer	8.66e-05	0.000437	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—skin cancer	8.66e-05	0.000437	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—skin cancer	8.07e-05	0.000407	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—skin cancer	7.86e-05	0.000396	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—skin cancer	7.75e-05	0.000391	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—skin cancer	7.49e-05	0.000378	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—skin cancer	7.24e-05	0.000365	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—skin cancer	6.96e-05	0.000351	CcSEcCtD
Omeprazole—Rash—Docetaxel—skin cancer	6.9e-05	0.000348	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—skin cancer	6.9e-05	0.000348	CcSEcCtD
Omeprazole—Headache—Docetaxel—skin cancer	6.86e-05	0.000346	CcSEcCtD
Omeprazole—Nausea—Docetaxel—skin cancer	6.5e-05	0.000328	CcSEcCtD
Omeprazole—ABCB1—lymph node—skin cancer	6.38e-05	0.0039	CbGeAlD
